Mario Gabelli Charles River Laboratories International, Inc. Transaction History

Gamco Investors, Inc. Et Al

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$118.84 - $189.72 $956,662 - $1.53 Million	-8,050 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$98.9 - $178.34 $4,945 - $8,917	50 Added 0.63%	8,050 $1.02 Million
Q4 2019 Feb 14, 2020	BUY	$126.05 - $152.76 $126,050 - $152,760	1,000 Added 14.29%	8,000 $1.22 Million
Q2 2019 Aug 02, 2019	BUY	$123.4 - $148.55 $246,800 - $297,100	2,000 Added 40.0%	7,000 $993,000
Q4 2018 Jan 30, 2019	SELL	$105.09 - $137.23 $210,180 - $274,460	-2,000 Reduced 28.57%	5,000 $566,000
Q3 2018 Nov 02, 2018	SELL	$112.11 - $134.54 $224,220 - $269,080	-2,000 Reduced 22.22%	7,000 $942,000
Q2 2018 Aug 10, 2018	BUY	$102.37 - $117.25 $204,740 - $234,500	2,000 Added 28.57%	9,000 $1.01 Million
Q1 2018 May 09, 2018	BUY	$98.19 - $115.2 $196,380 - $230,400	2,000 Added 40.0%	7,000 $747,000
Q4 2017 Feb 02, 2018	BUY	$100.43 - $118.09 $502,150 - $590,450	5,000	5,000 $547,000

693

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.55B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Gamco Investors, Inc. Et Al, based on Form 13F filings with the SEC.

Stay updated on Gamco Investors, Inc. Et Al and Mario Gabelli with notifications on news.